A guidance document from the US Food and Drug Administration (FDA) that addresses biotin interference testing for in vitro diagnostic devices (IVDs) has been finalized. The agency left the 2019 draft ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results